Suchergebnisse - "Alahmdi, Mohamed Issa"

PubPharm (9)

1

Therapeutic Path to Triple Knockout : Investigating the Pan-inhibitory Mechanisms of AKT, CDK9, and TNKS2 by a novel 2-Phenylquinazolinone derivative in Cancer Therapy- An In-Silico Investigation

enthalten in: Current pharmaceutical biotechnology | 2023

von Peters, X. | Elamin, G. | Aljoundi, A. | +7

2

Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds

enthalten in: Journal of molecular modeling | 2023

von Issahaku, A. | Mncube, S. | Agoni, C. | +9

3

Multi-dimensional structural footprint identification for the design of potential scaffolds targeting METTL3 in cancer treatment from natural compounds

enthalten in: Journal of molecular modeling | 2023

von Issahaku, A. | Mncube, S. | Agoni, C. | +9

4

Probing into the Flap-dimer Dynamics of the Mycobacterium tuberculosis Kasa Enzyme Binding Landscape Provides the Underlying Inhibitory Mechanisms of JSF-3285 and 5G

enthalten in: Current topics in medicinal chemistry | 2023

von Adewumi, A. | Oluyemi, W. | Adewumi, N. | +4

5

Propitious Indazole Compounds as β‐ketoacyl‐ACP Synthase Inhibitors and Mechanisms Unfolded for TB Cure : Integrated Rational Design and MD Simulations

enthalten in: ChemistrySelect | 2023

von Adewumi, A. | Oluyemi, W. | Adekunle, Y. | +4

6

Bridging the Gap in Malaria Parasite Resistance, Current Interventions, and the Way Forward from in Silico Perspective : A Review

enthalten in: Molecules (Basel, Switzerland) | 2022

von Kumi, R. | Oti, B. | Abo-Dya, N. | +2

7

Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy : structural mechanistic insights on the role of fenebrutinib

enthalten in: Journal of molecular modeling | 2022

von Elamin, G. | Aljoundi, A. | Alahmdi, M. | +2

8

Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinib

enthalten in: Journal of molecular modeling | 2022

von Elamin, G. | Aljoundi, A. | Alahmdi, M. | +2

9

Battling BTK mutants with noncovalent inhibitors that overcome Cys481 and Thr474 mutations in Waldenström macroglobulinemia therapy: structural mechanistic insights on the role of fenebrutinib

enthalten in: Journal of molecular modeling | 2022

von Elamin, G. | Aljoundi, A. | Alahmdi, M. | +2

1
[1]